{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T02:20:00Z","timestamp":1783045200648,"version":"3.54.6"},"reference-count":165,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":53,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"DOI":"10.1186\/s12943-026-02669-8","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T02:13:39Z","timestamp":1778465619000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["From guardians to traitors: molecular mechanisms of tumor-induced T cell betrayal"],"prefix":"10.1186","volume":"25","author":[{"given":"Pengxi","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anqi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bufu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hank Z. H.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonino","family":"Glaviano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,11]]},"reference":[{"issue":"1","key":"2669_CR1","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1146\/annurev-immunol-090222-110914","volume":"42","author":"A Baessler","year":"2024","unstructured":"Baessler A, Vignali DAA. T Cell Exhaustion. Annu Rev Immunol. 2024;42(1):179\u2013206. https:\/\/doi.org\/10.1146\/annurev-immunol-090222-110914. PubMed PMID: 38166256.","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"2669_CR2","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s10555-024-10167-w","volume":"43","author":"V Singh","year":"2024","unstructured":"Singh V, Nandi S, Ghosh A, Adhikary S, Mukherjee S, Roy S, et al. Epigenetic reprogramming of T cells: unlocking new avenues for cancer immunotherapy. Cancer Metastasis Rev. 2024;43(1):175\u201395. https:\/\/doi.org\/10.1007\/s10555-024-10167-w. PubMed PMID: 38233727.","journal-title":"Cancer Metastasis Rev"},{"issue":"6","key":"2669_CR3","doi-asserted-by":"publisher","first-page":"929","DOI":"10.3390\/biology11060929","volume":"11","author":"A Bo\u017cyk","year":"2022","unstructured":"Bo\u017cyk A, Wojas-Krawczyk K, Krawczyk P, Milanowski J. Tumor Microenvironment-A Short Review of Cellular and Interaction Diversity. Biology. 2022;11(6):929. doi:10.3390\/biology11060929 PubMed PMID: 35741450; PubMed Central PMCID: PMC9220289.","journal-title":"Biology"},{"key":"2669_CR4","doi-asserted-by":"publisher","first-page":"1151632","DOI":"10.3389\/fimmu.2023.1151632","volume":"14","author":"AE Brunell","year":"2023","unstructured":"Brunell AE, Lahesmaa R, Autio A, Thotakura AK. Exhausted T cells hijacking the cancer-immunity cycle: Assets and liabilities. Front Immunol. 2023;14:1151632. https:\/\/doi.org\/10.3389\/fimmu.2023.1151632. PubMed PMID: 37122741; PubMed Central PMCID: PMC10140554.","journal-title":"Front Immunol"},{"issue":"9","key":"2669_CR5","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1158\/0008-5472.CAN-11-3687","volume":"72","author":"A Facciabene","year":"2012","unstructured":"Facciabene A, Motz GT, Coukos G. T-regulatory cells: key players in tumor immune escape and angiogenesis. Cancer Res. 2012;72(9):2162\u201371. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-3687. PubMed PMID: 22549946; PubMed Central PMCID: PMC3342842.","journal-title":"Cancer Res"},{"issue":"10","key":"2669_CR6","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1038\/s41401-024-01304-w","volume":"45","author":"XH Liang","year":"2024","unstructured":"Liang XH, Chen XY, Yan Y, Cheng AY, Lin JY, Jiang YX, et al. Targeting metabolism to enhance immunotherapy within tumor microenvironment. Acta Pharmacol Sin. 2024;45(10):2011\u201322. https:\/\/doi.org\/10.1038\/s41401-024-01304-w. PubMed PMID: 38811773; PubMed Central PMCID: PMC11420344.","journal-title":"Acta Pharmacol Sin"},{"issue":"2","key":"2669_CR7","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.immuni.2016.07.009","volume":"45","author":"NE Scharping","year":"2016","unstructured":"Scharping NE, Menk AV, Moreci RS, Whetstone RD, Dadey RE, Watkins SC, et al. The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction. Immunity. 2016;45(2):374\u201388. https:\/\/doi.org\/10.1016\/j.immuni.2016.07.009. PubMed PMID: 27496732; PubMed Central PMCID: PMC5207350.","journal-title":"Immunity"},{"issue":"12","key":"2669_CR8","doi-asserted-by":"publisher","first-page":"e3002943","DOI":"10.1371\/journal.pbio.3002943","volume":"22","author":"ML Lawton","year":"2024","unstructured":"Lawton ML, Inge MM, Blum BC, Smith-Mahoney EL, Bolzan D, Lin W, et al. Multiomic profiling of chronically activated CD4\u2009+\u2009T cells identifies drivers of exhaustion and metabolic reprogramming. PLoS Biol. 2024;22(12):e3002943. https:\/\/doi.org\/10.1371\/journal.pbio.3002943. PubMed PMID: 39689157; PubMed Central PMCID: PMC11703073.","journal-title":"PLoS Biol"},{"key":"2669_CR9","doi-asserted-by":"publisher","first-page":"0723","DOI":"10.34133\/research.0723","volume":"8","author":"A Lin","year":"2025","unstructured":"Lin A, Ye P, Li Z, Jiang A, Liu Z, Cheng Q, et al. Natural Killer Cell Immune Checkpoints and Their Therapeutic Targeting in Cancer Treatment. Research. 2025;8:0723. https:\/\/doi.org\/10.34133\/research.0723. PubMed PMID: 40463500; PubMed Central PMCID: PMC12131497.","journal-title":"Research"},{"issue":"8","key":"2669_CR10","doi-asserted-by":"publisher","first-page":"e13644","DOI":"10.1111\/cpr.13644","volume":"57","author":"L Yu","year":"2024","unstructured":"Yu L, Huang K, Liao Y, Wang L, Sethi G, Ma Z. Targeting novel regulated cell death: Ferroptosis, pyroptosis and necroptosis in anti-PD-1\/PD-L1 cancer immunotherapy. Cell Prolif. 2024;57(8):e13644. https:\/\/doi.org\/10.1111\/cpr.13644. PubMed PMID: 38594879; PubMed Central PMCID: PMC11294428.","journal-title":"Cell Prolif"},{"issue":"3","key":"2669_CR11","doi-asserted-by":"publisher","first-page":"e97","DOI":"10.1002\/mef2.97","volume":"3","author":"Y Tan","year":"2024","unstructured":"Tan Y, Yu Y. CAPability-01: Success of anti-PD-1, HDAC inhibitor, and anti-VEGF combination in colorectal cancer. MedComm \u2013 Future Med. 2024;3(3):e97. https:\/\/doi.org\/10.1002\/mef2.97.","journal-title":"MedComm \u2013 Future Med"},{"key":"2669_CR12","doi-asserted-by":"publisher","first-page":"1267816","DOI":"10.3389\/fimmu.2023.1267816","volume":"14","author":"A Kirchmair","year":"2023","unstructured":"Kirchmair A, Nemati N, Lamberti G, Trefny M, Krogsdam A, Siller A, et al. 13\u00a0C tracer analysis reveals the landscape of metabolic checkpoints in human CD8\u2009+\u2009T cell differentiation and exhaustion. Front Immunol. 2023;14:1267816. https:\/\/doi.org\/10.3389\/fimmu.2023.1267816. PubMed PMID: 37928527; PubMed Central PMCID: PMC10620935.","journal-title":"Front Immunol"},{"issue":"1","key":"2669_CR13","doi-asserted-by":"publisher","first-page":"e010403","DOI":"10.1136\/jitc-2024-010403","volume":"13","author":"Y Xu","year":"2025","unstructured":"Xu Y, Ding L, Wu M, Wang X, Wang L, Xu Z, et al. Lipid metabolic remodeling delays senescence of T cells to potentiate their immunity against solid tumors. J Immunother Cancer. 2025;13(1):e010403. https:\/\/doi.org\/10.1136\/jitc-2024-010403. PubMed PMID: 39762081; PubMed Central PMCID: PMC11749770.","journal-title":"J Immunother Cancer"},{"key":"2669_CR14","doi-asserted-by":"publisher","first-page":"1248339","DOI":"10.3389\/fonc","volume":"13","author":"S Rai","year":"2023","unstructured":"Rai S, Roy G, Hajam YA. Melatonin: a modulator in metabolic rewiring in T-cell malignancies. Front Oncol. 2023;13:1248339. https:\/\/doi.org\/10.3389\/fonc. 2023.1248339 PubMed PMID: 38260850; PubMed Central PMCID: PMC10800968.","journal-title":"Front Oncol"},{"issue":"10","key":"2669_CR15","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/s42255-020-00280-9","volume":"2","author":"F Franco","year":"2020","unstructured":"Franco F, Jaccard A, Romero P, Yu YR, Ho PC. Metabolic and epigenetic regulation of T-cell exhaustion. Nat Metab. 2020;2(10):1001\u201312. https:\/\/doi.org\/10.1038\/s42255-020-00280-9. PubMed PMID: 32958939.","journal-title":"Nat Metab"},{"issue":"5","key":"2669_CR16","doi-asserted-by":"publisher","first-page":"189162","DOI":"10.1016\/j.bbcan.2024.189162","volume":"1879","author":"K Kang","year":"2024","unstructured":"Kang K, Lin X, Chen P, Liu H, Liu F, Xiong W, et al. T cell exhaustion in human cancers. Biochim Biophys Acta Rev Cancer. 2024;1879(5):189162. https:\/\/doi.org\/10.1016\/j.bbcan.2024.189162. PubMed PMID: 39089484.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"2669_CR17","doi-asserted-by":"publisher","first-page":"693215","DOI":"10.3389\/fcell.2021.693215","volume":"9","author":"R Qiu","year":"2021","unstructured":"Qiu R, Zhong Y, Li Q, Li Y, Fan H. Metabolic Remodeling in Glioma Immune Microenvironment: Intercellular Interactions Distinct From Peripheral Tumors. Front Cell Dev Biol. 2021;9:693215. https:\/\/doi.org\/10.3389\/fcell.2021.693215. PubMed PMID: 34211978; PubMed Central PMCID: PMC8239469.","journal-title":"Front Cell Dev Biol"},{"issue":"9","key":"2669_CR18","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1158\/0008-5472.CAN-12-3696","volume":"73","author":"I Kareva","year":"2013","unstructured":"Kareva I, Hahnfeldt P. The emerging hallmarks of metabolic reprogramming and immune evasion: distinct or linked? Cancer Res. 2013;73(9):2737\u201342. https:\/\/doi.org\/10.1158\/0008-5472.CAN-12-3696. PubMed PMID: 23423980.","journal-title":"Cancer Res"},{"issue":"Suppl 8","key":"2669_CR19","doi-asserted-by":"publisher","first-page":"viii6","DOI":"10.1093\/annonc\/mds256","volume":"23","author":"OJ Finn","year":"2012","unstructured":"Finn OJ. Immuno-oncology: understanding the function and dysfunction of the immune system in cancer. Ann Oncol Off J Eur Soc Med Oncol. 2012;23(Suppl 8):viii6\u20139. https:\/\/doi.org\/10.1093\/annonc\/mds256. PubMed PMID: 22918931; PubMed Central PMCID: PMC4085883.","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"issue":"51","key":"2669_CR20","doi-asserted-by":"publisher","first-page":"7393","DOI":"10.1016\/j.vaccine.2015.08.096","volume":"33","author":"AB Frey","year":"2015","unstructured":"Frey AB. Suppression of T cell responses in the tumor microenvironment. Vaccine. 2015;33(51):7393\u2013400. https:\/\/doi.org\/10.1016\/j.vaccine.2015.08.096. PubMed PMID: 26403368.","journal-title":"Vaccine"},{"issue":"3","key":"2669_CR21","doi-asserted-by":"publisher","first-page":"446","DOI":"10.21147\/j.issn.1000-9604.2025.03.12","volume":"37","author":"J Zou","year":"2025","unstructured":"Zou J, Wang S, Zhang Y, Tian W, Mai G, Xu Y, et al. Tumor-educated cells in tumor microenvironment: Key drivers of immunotherapy resistance. Chin J Cancer Res Chung-Kuo Yen Cheng Yen Chiu. 2025;37(3):446\u201365. https:\/\/doi.org\/10.21147\/j.issn.1000-9604.2025.03.12. PubMed PMID: 40642484; PubMed Central PMCID: PMC12240242.","journal-title":"Chin J Cancer Res Chung-Kuo Yen Cheng Yen Chiu"},{"issue":"2","key":"2669_CR22","doi-asserted-by":"publisher","first-page":"e2202937","DOI":"10.1002\/advs.202202937","volume":"10","author":"N Niu","year":"2023","unstructured":"Niu N, Shen X, Zhang L, Chen Y, Lu P, Yang W, et al. Tumor Cell-Intrinsic SETD2 Deficiency Reprograms Neutrophils to Foster Immune Escape in Pancreatic Tumorigenesis. Adv Sci Weinh Baden-Wurtt Ger. 2023;10(2):e2202937. https:\/\/doi.org\/10.1002\/advs.202202937. PubMed PMID: 36453584; PubMed Central PMCID: PMC9839845.","journal-title":"Adv Sci Weinh Baden-Wurtt Ger"},{"issue":"10","key":"2669_CR23","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1016\/j.immuni.2023.09.005","volume":"56","author":"JR Giles","year":"2023","unstructured":"Giles JR, Globig AM, Kaech SM, Wherry EJ. CD8\u2009+\u2009T cells in the cancer-immunity cycle. Immunity. 2023;56(10):2231\u201353. https:\/\/doi.org\/10.1016\/j.immuni.2023.09.005. PubMed PMID: 37820583; PubMed Central PMCID: PMC11237652.","journal-title":"Immunity"},{"issue":"12","key":"2669_CR24","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1016\/j.ccell.2024.10.012","volume":"42","author":"CX Huang","year":"2024","unstructured":"Huang CX, Lao XM, Wang XY, Ren YZ, Lu YT, Shi W, et al. Pericancerous cross-presentation to cytotoxic T lymphocytes impairs immunotherapeutic efficacy in hepatocellular carcinoma. Cancer Cell. 2024;42(12):2082\u2013e209710. https:\/\/doi.org\/10.1016\/j.ccell.2024.10.012. PubMed PMID: 39547231.","journal-title":"Cancer Cell"},{"issue":"6603","key":"2669_CR25","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1126\/science.abj8695","volume":"377","author":"BS Reis","year":"2022","unstructured":"Reis BS, Darcy PW, Khan IZ, Moon CS, Kornberg AE, Schneider VS, et al. TCR-V\u03b3\u03b4 usage distinguishes protumor from antitumor intestinal \u03b3\u03b4 T cell subsets. Science. 2022;377(6603):276\u201384. https:\/\/doi.org\/10.1126\/science.abj8695. PubMed PMID: 35857588; PubMed Central PMCID: PMC9326786.","journal-title":"Science"},{"issue":"1","key":"2669_CR26","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12943-023-01722-0","volume":"22","author":"Z Gao","year":"2023","unstructured":"Gao Z, Bai Y, Lin A, Jiang A, Zhou C, Cheng Q, et al. Gamma delta T-cell-based immune checkpoint therapy: attractive candidate for antitumor treatment. Mol Cancer. 2023;22(1):31. https:\/\/doi.org\/10.1186\/s12943-023-01722-0. PubMed PMID: 36793048; PubMed Central PMCID: PMC9930367.","journal-title":"Mol Cancer"},{"key":"2669_CR27","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.3389\/fimmu.2018.03171","volume":"9","author":"G Di Lullo","year":"2018","unstructured":"Di Lullo G, Marcatti M, Heltai S, Tresoldi C, Paganoni AM, Bordignon C, et al. Immunomodulatory Drugs in the Context of Autologous Hematopoietic Stem Cell Transplantation Associate With Reduced Pro-tumor T Cell Subsets in Multiple Myeloma. Front Immunol. 2018;9:3171. https:\/\/doi.org\/10.3389\/fimmu.2018.03171. PubMed PMID: 30719025; PubMed Central PMCID: PMC6348257.","journal-title":"Front Immunol"},{"issue":"1","key":"2669_CR28","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.tcb.2018.07.006","volume":"29","author":"H Loo Yau","year":"2019","unstructured":"Loo Yau H, Ettayebi I, De Carvalho DD. The Cancer Epigenome: Exploiting Its Vulnerabilities for Immunotherapy. Trends Cell Biol. 2019;29(1):31\u201343. https:\/\/doi.org\/10.1016\/j.tcb.2018.07.006. PubMed PMID: 30153961.","journal-title":"Trends Cell Biol"},{"issue":"88","key":"2669_CR29","doi-asserted-by":"publisher","first-page":"eadf8838","DOI":"10.1126\/sciimmunol.adf8838","volume":"8","author":"PE Bont\u00e9","year":"2023","unstructured":"Bont\u00e9 PE, Metoikidou C, Heurtebise-Chretien S, Arribas YA, Del Sutra A, Ye M, et al. Selective control of transposable element expression during T cell exhaustion and anti-PD-1 treatment. Sci Immunol. 2023;8(88):eadf8838. https:\/\/doi.org\/10.1126\/sciimmunol.adf8838. PubMed PMID: 37889984.","journal-title":"Sci Immunol"},{"issue":"1","key":"2669_CR30","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1007\/s11033-024-09882-y","volume":"51","author":"JT Low","year":"2024","unstructured":"Low JT, Chan MWY, Shen CH, Wei KL. Immunological hide-and-seek: epigenetically reprogrammed cancer cells and the dynamics of CD8\u2009+\u2009T cells. Mol Biol Rep. 2024;51(1):959. https:\/\/doi.org\/10.1007\/s11033-024-09882-y. PubMed PMID: 39230620.","journal-title":"Mol Biol Rep"},{"issue":"2","key":"2669_CR31","doi-asserted-by":"publisher","first-page":"e142513","DOI":"10.1172\/jci.insight.142513","volume":"6","author":"CC Balan\u00e7a","year":"2021","unstructured":"Balan\u00e7a CC, Salvioni A, Scarlata CM, Michelas M, Martinez-Gomez C, Gomez-Roca C, et al. PD-1 blockade restores helper activity of tumor-infiltrating, exhausted PD-1hiCD39\u2009+\u2009CD4 T cells. JCI Insight. 2021;6(2):e142513. https:\/\/doi.org\/10.1172\/jci.insight.142513. PubMed PMID: 33332284; PubMed Central PMCID: PMC7934837.","journal-title":"JCI Insight"},{"issue":"8","key":"2669_CR32","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/s41419-024-06895-0","volume":"15","author":"G Wang","year":"2024","unstructured":"Wang G, Shen X, Jin W, Song C, Dong M, Zhou Z, et al. Elucidating the role of S100A10 in CD8\u2009+\u2009T cell exhaustion and HCC immune escape via the cPLA2 and 5-LOX axis. Cell Death Dis. 2024;15(8):573. https:\/\/doi.org\/10.1038\/s41419-024-06895-0. PubMed PMID: 39117605; PubMed Central PMCID: PMC11310305.","journal-title":"Cell Death Dis"},{"issue":"8","key":"2669_CR33","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.3390\/cancers12082274","volume":"12","author":"D Saka","year":"2020","unstructured":"Saka D, G\u00f6kalp M, Piyade B, Cevik NC, Arik Sever E, Unutmaz D, et al. Mechanisms of T-Cell Exhaustion in Pancreatic Cancer. Cancers. 2020;12(8):2274. https:\/\/doi.org\/10.3390\/cancers12082274. PubMed PMID: 32823814; PubMed Central PMCID: PMC7464444.","journal-title":"Cancers"},{"issue":"1","key":"2669_CR34","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1182\/blood.2018885863","volume":"134","author":"JAC van Bruggen","year":"2019","unstructured":"van Bruggen JAC, Martens AWJ, Fraietta JA, Hofland T, Tonino SH, Eldering E, et al. Chronic lymphocytic leukemia cells impair mitochondrial fitness in CD8\u2009+\u2009T cells and impede CAR T-cell efficacy. Blood. 2019;134(1):44\u201358. https:\/\/doi.org\/10.1182\/blood.2018885863. PubMed PMID: 31076448; PubMed Central PMCID: PMC7022375.","journal-title":"Blood"},{"key":"2669_CR35","doi-asserted-by":"publisher","first-page":"216267","DOI":"10.1016\/j.canlet.2023.216267","volume":"567","author":"R Wang","year":"2023","unstructured":"Wang R, Liu Z, Fan Z, Zhan H. Lipid metabolism reprogramming of CD8\u2009+\u2009T cell and therapeutic implications in cancer. Cancer Lett. 2023;567:216267. https:\/\/doi.org\/10.1016\/j.canlet.2023.216267. PubMed PMID: 37315709.","journal-title":"Cancer Lett"},{"issue":"1","key":"2669_CR36","doi-asserted-by":"publisher","first-page":"6858","DOI":"10.1038\/s41467-023-42634-3","volume":"14","author":"H Wu","year":"2023","unstructured":"Wu H, Zhao X, Hochrein SM, Eckstein M, Gubert GF, Kn\u00f6pper K, et al. Mitochondrial dysfunction promotes the transition of precursor to terminally exhausted T cells through HIF-1\u03b1-mediated glycolytic reprogramming. Nat Commun. 2023;14(1):6858. https:\/\/doi.org\/10.1038\/s41467-023-42634-3. PubMed PMID: 37891230; PubMed Central PMCID: PMC10611730.","journal-title":"Nat Commun"},{"issue":"10","key":"2669_CR37","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1182\/blood.2022015956","volume":"140","author":"N Philipp","year":"2022","unstructured":"Philipp N, Kazerani M, Nicholls A, Vick B, Wulf J, Straub T, et al. T-cell exhaustion induced by continuous bispecific molecule exposure is ameliorated by treatment-free intervals. Blood. 2022;140(10):1104\u201318. https:\/\/doi.org\/10.1182\/blood.2022015956. PubMed PMID: 35878001; PubMed Central PMCID: PMC10652962.","journal-title":"Blood"},{"issue":"1","key":"2669_CR38","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s12943-019-1091-2","volume":"18","author":"S Qin","year":"2019","unstructured":"Qin S, Xu L, Yi M, Yu S, Wu K, Luo S. Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4. Mol Cancer. 2019;18(1):155. https:\/\/doi.org\/10.1186\/s12943-019-1091-2. PubMed PMID: 31690319; PubMed Central PMCID: PMC6833286.","journal-title":"Mol Cancer"},{"issue":"22","key":"2669_CR39","doi-asserted-by":"publisher","first-page":"12223","DOI":"10.3390\/ijms252212223","volume":"25","author":"J Wang","year":"2024","unstructured":"Wang J, He Y, Hu F, Hu C, Sun Y, Yang K, et al. Metabolic Reprogramming of Immune Cells in the Tumor Microenvironment. Int J Mol Sci. 2024;25(22):12223. https:\/\/doi.org\/10.3390\/ijms252212223. PubMed PMID: 39596288; PubMed Central PMCID: PMC11594648.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"2669_CR40","doi-asserted-by":"publisher","first-page":"C1062","DOI":"10.1152\/ajpcell.00478.2024","volume":"328","author":"N Jantz-Naeem","year":"2025","unstructured":"Jantz-Naeem N, Guvencli N, B\u00f6ttcher-Loschinski R, B\u00f6ttcher M, Mougiakakos D, Kahlfuss S. Metabolic T-cell phenotypes: from bioenergetics to function. Am J Physiol Cell Physiol. 2025;328(3):C1062\u201375. https:\/\/doi.org\/10.1152\/ajpcell.00478.2024. PubMed PMID: 39946684.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"7","key":"2669_CR41","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1097\/CM9.0000000000002989","volume":"137","author":"X Pan","year":"2024","unstructured":"Pan X, Wang J, Zhang L, Li G, Huang B. Metabolic plasticity of T cell fate decision. Chin Med J (Engl). 2024;137(7):762\u201375. https:\/\/doi.org\/10.1097\/CM9.0000000000002989. PubMed PMID: 38086394; PubMed Central PMCID: PMC10997312.","journal-title":"Chin Med J (Engl)"},{"issue":"5","key":"2669_CR42","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1084\/jem.20101773","volume":"208","author":"LM Fahey","year":"2011","unstructured":"Fahey LM, Wilson EB, Elsaesser H, Fistonich CD, McGavern DB, Brooks DG. Viral persistence redirects CD4 T cell differentiation toward T follicular helper cells. J Exp Med. 2011;208(5):987\u201399. https:\/\/doi.org\/10.1084\/jem.20101773. PubMed PMID: 21536743; PubMed Central PMCID: PMC3092345.","journal-title":"J Exp Med"},{"issue":"1","key":"2669_CR43","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1038\/s41467-018-04524-x","volume":"9","author":"R Alonso","year":"2018","unstructured":"Alonso R, Flament H, Lemoine S, Sedlik C, Bottasso E, P\u00e9guillet I, et al. Induction of anergic or regulatory tumor-specific CD4\u2009+\u2009T cells in the tumor-draining lymph node. Nat Commun. 2018;9(1):2113. https:\/\/doi.org\/10.1038\/s41467-018-04524-x. PubMed PMID: 29844317; PubMed Central PMCID: PMC5974295.","journal-title":"Nat Commun"},{"issue":"6","key":"2669_CR44","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.ccell.2022.04.011","volume":"40","author":"H Huang","year":"2022","unstructured":"Huang H, Wang Z, Zhang Y, Pradhan RN, Ganguly D, Chandra R, et al. Mesothelial cell-derived antigen-presenting cancer-associated fibroblasts induce expansion of regulatory T cells in pancreatic cancer. Cancer Cell. 2022;40(6):656\u2013e6737. https:\/\/doi.org\/10.1016\/j.ccell.2022.04.011. PubMed PMID: 35523176; PubMed Central PMCID: PMC9197998.","journal-title":"Cancer Cell"},{"issue":"1","key":"2669_CR45","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.immuni.2015.12.018","volume":"44","author":"N Malandro","year":"2016","unstructured":"Malandro N, Budhu S, Kuhn NF, Liu C, Murphy JT, Cortez C, et al. Clonal Abundance of Tumor-Specific CD4(+) T Cells Potentiates Efficacy and Alters Susceptibility to Exhaustion. Immunity. 2016;44(1):179\u201393. .018 PubMed PMID: 26789923; PubMed Central PMCID: PMC4996670.","journal-title":"Immunity"},{"key":"2669_CR46","doi-asserted-by":"publisher","first-page":"115976","DOI":"10.1016\/j.biopha.2023.115976","volume":"170","author":"Q Shang","year":"2024","unstructured":"Shang Q, Yu X, Sun Q, Li H, Sun C, Liu L. Polysaccharides regulate Th1\/Th2 balance: A new strategy for tumor immunotherapy. Biomed Pharmacother Biomedecine Pharmacother. 2024;170:115976. https:\/\/doi.org\/10.1016\/j.biopha.2023.115976. PubMed PMID: 38043444.","journal-title":"Biomed Pharmacother Biomedecine Pharmacother"},{"issue":"4","key":"2669_CR47","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.it.2024.02.005","volume":"45","author":"M Guo","year":"2024","unstructured":"Guo M, Liu MYR, Brooks DG. Regulation and impact of tumor-specific CD4\u2009+\u2009T cells in cancer and immunotherapy. Trends Immunol. 2024;45(4):303\u201313. https:\/\/doi.org\/10.1016\/j.it.2024.02.005. PubMed PMID: 38508931.","journal-title":"Trends Immunol"},{"issue":"8049","key":"2669_CR48","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41586-024-08439-0","volume":"638","author":"H Ikeda","year":"2025","unstructured":"Ikeda H, Kawase K, Nishi T, Watanabe T, Takenaga K, Inozume T, et al. Immune evasion through mitochondrial transfer in the tumour microenvironment. Nature. 2025;638(8049):225\u201336. https:\/\/doi.org\/10.1038\/s41586-024-08439-0. PubMed PMID: 39843734; PubMed Central PMCID: PMC11798832.","journal-title":"Nature"},{"issue":"1","key":"2669_CR49","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/s41565-021-01000-4","volume":"17","author":"T Saha","year":"2022","unstructured":"Saha T, Dash C, Jayabalan R, Khiste S, Kulkarni A, Kurmi K, et al. Intercellular nanotubes mediate mitochondrial trafficking between cancer and immune cells. Nat Nanotechnol. 2022;17(1):98\u2013106. https:\/\/doi.org\/10.1038\/s41565-021-01000-4. PubMed PMID: 34795441; PubMed Central PMCID: PMC10071558.","journal-title":"Nat Nanotechnol"},{"issue":"3","key":"2669_CR50","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/s43018-023-00521-2","volume":"4","author":"DE Speiser","year":"2023","unstructured":"Speiser DE, Chijioke O, Schaeuble K, M\u00fcnz C. CD4\u2009+\u2009T cells in cancer. Nat Cancer. 2023;4(3):317\u201329. https:\/\/doi.org\/10.1038\/s43018-023-00521-2. PubMed PMID: 36894637.","journal-title":"Nat Cancer"},{"issue":"1","key":"2669_CR51","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ccell.2024.11.011","volume":"43","author":"CT Kureshi","year":"2025","unstructured":"Kureshi CT, Dougan SK. Cytokines in cancer. Cancer Cell. 2025;43(1):15\u201335. https:\/\/doi.org\/10.1016\/j.ccell.2024.11.011. PubMed PMID: 39672170; PubMed Central PMCID: PMC11841838.","journal-title":"Cancer Cell"},{"issue":"9","key":"2669_CR52","doi-asserted-by":"publisher","first-page":"5693","DOI":"10.4049\/jimmunol.0900092","volume":"182","author":"CA Corzo","year":"2009","unstructured":"Corzo CA, Cotter MJ, Cheng P, Cheng F, Kusmartsev S, Sotomayor E, et al. Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells. J Immunol Baltim Md 1950. 2009;182(9):5693\u2013701. https:\/\/doi.org\/10.4049\/jimmunol.0900092. PubMed PMID: 19380816; PubMed Central PMCID: PMC2833019.","journal-title":"J Immunol Baltim Md 1950"},{"issue":"2","key":"2669_CR53","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ccell.2022.01.003","volume":"40","author":"A Alam","year":"2022","unstructured":"Alam A, Levanduski E, Denz P, Villavicencio HS, Bhatta M, Alhorebi L, et al. Fungal mycobiome drives IL-33 secretion and type 2 immunity in pancreatic cancer. Cancer Cell. 2022;40(2):153\u2013e16711. https:\/\/doi.org\/10.1016\/j.ccell.2022.01.003. PubMed PMID: 35120601; PubMed Central PMCID: PMC8847236.","journal-title":"Cancer Cell"},{"issue":"1","key":"2669_CR54","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/cr.2016.151","volume":"27","author":"A Tanaka","year":"2017","unstructured":"Tanaka A, Sakaguchi S. Regulatory T cells in cancer immunotherapy. Cell Res. 2017;27(1):109\u201318. https:\/\/doi.org\/10.1038\/cr.2016.151. PubMed PMID: 27995907; PubMed Central PMCID: PMC5223231.","journal-title":"Cell Res"},{"issue":"4","key":"2669_CR55","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.immuni.2019.03.020","volume":"50","author":"W Ouyang","year":"2019","unstructured":"Ouyang W, O\u2019Garra A. IL-10 Family Cytokines IL-10 and IL-22: from Basic Science to Clinical Translation. Immunity. 2019;50(4):871\u201391. https:\/\/doi.org\/10.1016\/j.immuni.2019.03.020. PubMed PMID: 30995504.","journal-title":"Immunity"},{"issue":"8","key":"2669_CR56","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1136\/gutjnl-2022-327855","volume":"72","author":"FSR Picard","year":"2023","unstructured":"Picard FSR, Lutz V, Brichkina A, Neuhaus F, Ruckenbrod T, Hupfer A, et al. IL-17A-producing CD8\u2009+\u2009T cells promote PDAC via induction of inflammatory cancer-associated fibroblasts. Gut. 2023;72(8):1510\u201322. https:\/\/doi.org\/10.1136\/gutjnl-2022-327855. PubMed PMID: 36759154; PubMed Central PMCID: PMC10359545.","journal-title":"Gut"},{"issue":"1","key":"2669_CR57","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.cmet.2022.11.013","volume":"35","author":"HN Bell","year":"2023","unstructured":"Bell HN, Huber AK, Singhal R, Korimerla N, Rebernick RJ, Kumar R, et al. Microenvironmental ammonia enhances T cell exhaustion in colorectal cancer. Cell Metab. 2023;35(1):134\u2013e1496. https:\/\/doi.org\/10.1016\/j.cmet.2022.11.013. PubMed PMID: 36528023; PubMed Central PMCID: PMC9841369.","journal-title":"Cell Metab"},{"key":"2669_CR58","doi-asserted-by":"publisher","first-page":"1353787","DOI":"10.3389\/fimmu.2024.1353787","volume":"15","author":"A Nicolini","year":"2024","unstructured":"Nicolini A, Ferrari P. Involvement of tumor immune microenvironment metabolic reprogramming in colorectal cancer progression, immune escape, and response to immunotherapy. Front Immunol. 2024;15:1353787. https:\/\/doi.org\/10.3389\/fimmu.2024.1353787. PubMed PMID: 39119332; PubMed Central PMCID: PMC11306065.","journal-title":"Front Immunol"},{"issue":"1","key":"2669_CR59","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13045-022-01322-3","volume":"15","author":"Y Yan","year":"2022","unstructured":"Yan Y, Huang L, Liu Y, Yi M, Chu Q, Jiao D, et al. Metabolic profiles of regulatory T cells and their adaptations to the tumor microenvironment: implications for antitumor immunity. J Hematol OncolJ Hematol Oncol. 2022;15(1):104. https:\/\/doi.org\/10.1186\/s13045-022-01322-3. PubMed PMID: 35948909; PubMed Central PMCID: PMC9364625.","journal-title":"J Hematol OncolJ Hematol Oncol"},{"key":"2669_CR60","doi-asserted-by":"publisher","first-page":"1327717","DOI":"10.3389\/fphar.2023.1327717","volume":"14","author":"Y Liu","year":"2023","unstructured":"Liu Y, Wang T, Ma W, Jia Z, Wang Q, Zhang M, et al. Metabolic reprogramming in the tumor microenvironment: unleashing T cell stemness for enhanced cancer immunotherapy. Front Pharmacol. 2023;14:1327717. https:\/\/doi.org\/10.3389\/fphar.2023.1327717. PubMed PMID: 38169800; PubMed Central PMCID: PMC10758489.","journal-title":"Front Pharmacol"},{"key":"2669_CR61","doi-asserted-by":"publisher","first-page":"1268188","DOI":"10.3389\/fimmu.2023.1268188","volume":"14","author":"X Wu","year":"2023","unstructured":"Wu X, Zhou Z, Cao Q, Chen Y, Gong J, Zhang Q, et al. Reprogramming of Treg cells in the inflammatory microenvironment during immunotherapy: a literature review. Front Immunol. 2023;14:1268188. https:\/\/doi.org\/10.3389\/fimmu.2023.1268188. PubMed PMID: 37753092; PubMed Central PMCID: PMC10518452.","journal-title":"Front Immunol"},{"issue":"2","key":"2669_CR62","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41590-020-00834-9","volume":"22","author":"NE Scharping","year":"2021","unstructured":"Scharping NE, Rivadeneira DB, Menk AV, Vignali PDA, Ford BR, Rittenhouse NL, et al. Mitochondrial stress induced by continuous stimulation under hypoxia rapidly drives T cell exhaustion. Nat Immunol. 2021;22(2):205\u201315. https:\/\/doi.org\/10.1038\/s41590-020-00834-9. PubMed PMID: 33398183; PubMed Central PMCID: PMC7971090.","journal-title":"Nat Immunol"},{"issue":"16","key":"2669_CR63","doi-asserted-by":"publisher","first-page":"4003","DOI":"10.1158\/0008-5472.CAN-19-0617","volume":"79","author":"VM Ngwa","year":"2019","unstructured":"Ngwa VM, Edwards DN, Philip M, Chen J. Microenvironmental Metabolism Regulates Antitumor Immunity. Cancer Res. 2019;79(16):4003\u20138. https:\/\/doi.org\/10.1158\/0008-5472.CAN-19-0617. PubMed PMID: 31362930; PubMed Central PMCID: PMC6697577.","journal-title":"Cancer Res"},{"issue":"6","key":"2669_CR64","doi-asserted-by":"publisher","first-page":"652","DOI":"10.21147\/j.issn.1000-9604.2024.06.05","volume":"36","author":"J Li","year":"2024","unstructured":"Li J, Ping P, Li Y, Xu X. Fatty acid metabolism: A new target for nasopharyngeal carcinoma therapy. Chin J Cancer Res Chung-Kuo Yen Cheng Yen Chiu. 2024;36(6):652\u201368. https:\/\/doi.org\/10.21147\/j.issn.1000-9604.2024.06.05. PubMed PMID: 39802901; PubMed Central PMCID: PMC11724175.","journal-title":"Chin J Cancer Res Chung-Kuo Yen Cheng Yen Chiu"},{"issue":"9","key":"2669_CR65","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1016\/j.cmet.2023.07.001","volume":"35","author":"L Wu","year":"2023","unstructured":"Wu L, Jin Y, Zhao X, Tang K, Zhao Y, Tong L, et al. Tumor aerobic glycolysis confers immune evasion through modulating sensitivity to T cell-mediated bystander killing via TNF-\u03b1. Cell Metab. 2023;35(9):1580\u2013e15969. https:\/\/doi.org\/10.1016\/j.cmet.2023.07.001. PubMed PMID: 37506695.","journal-title":"Cell Metab"},{"issue":"6","key":"2669_CR66","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.cmet.2021.04.001","volume":"33","author":"Y Liu","year":"2021","unstructured":"Liu Y, Liang G, Xu H, Dong W, Dong Z, Qiu Z, et al. Tumors exploit FTO-mediated regulation of glycolytic metabolism to evade immune surveillance. Cell Metab. 2021;33(6):1221\u2013e123311. https:\/\/doi.org\/10.1016\/j.cmet.2021.04.001. PubMed PMID: 33910046.","journal-title":"Cell Metab"},{"issue":"4","key":"2669_CR67","doi-asserted-by":"publisher","first-page":"134","DOI":"10.31083\/j.fbl2904134","volume":"29","author":"J Pu","year":"2024","unstructured":"Pu J, Zhang D, Wang B, Zhu P, Yang W, Wang K, et al. FOXA1\/UBE2T Inhibits CD8\u2009+\u2009T Cell Activity by Inducing Mediates Glycolysis in Lung Adenocarcinoma. Front Biosci Landmark Ed. 2024;29(4):134. https:\/\/doi.org\/10.31083\/j.fbl2904134. PubMed PMID: 38682180.","journal-title":"Front Biosci Landmark Ed"},{"key":"2669_CR68","doi-asserted-by":"publisher","first-page":"1324045","DOI":"10.3389\/fimmu.2024.1324045","volume":"15","author":"S Venkatraman","year":"2024","unstructured":"Venkatraman S, Balasubramanian B, Thuwajit C, Meller J, Tohtong R, Chutipongtanate S. Targeting MYC at the intersection between cancer metabolism and oncoimmunology. Front Immunol. 2024;15:1324045. https:\/\/doi.org\/10.3389\/fimmu.2024.1324045. PubMed PMID: 38390324; PubMed Central PMCID: PMC10881682.","journal-title":"Front Immunol"},{"issue":"1","key":"2669_CR69","doi-asserted-by":"publisher","first-page":"7339","DOI":"10.1038\/s41598-023-34087-x","volume":"13","author":"CE Nunes-Xavier","year":"2023","unstructured":"Nunes-Xavier CE, Emaldi M, Mingo J, \u00d8yjord T, M\u00e6landsmo GM, Fodstad \u00d8, et al. The expression pattern of pyruvate dehydrogenase kinases predicts prognosis and correlates with immune exhaustion in clear cell renal cell carcinoma. Sci Rep. 2023;13(1):7339. https:\/\/doi.org\/10.1038\/s41598-023-34087-x. PubMed PMID: 37147361; PubMed Central PMCID: PMC10162970.","journal-title":"Sci Rep"},{"issue":"1","key":"2669_CR70","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12964-023-01455-z","volume":"22","author":"M Huang","year":"2024","unstructured":"Huang M, Yu X, Wang Q, Jiang Z, Li X, Chen W, et al. The immune checkpoint TIGIT\/CD155 promotes the exhaustion of CD8\u2009+\u2009T cells in TNBC through glucose metabolic reprogramming mediated by PI3K\/AKT\/mTOR signaling. Cell Commun Signal CCS. 2024;22(1):35. https:\/\/doi.org\/10.1186\/s12964-023-01455-z. PubMed PMID: 38216949; PubMed Central PMCID: PMC10785424.","journal-title":"Cell Commun Signal CCS"},{"issue":"1","key":"2669_CR71","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.cmet.2022.12.003","volume":"35","author":"CH Tsai","year":"2023","unstructured":"Tsai CH, Chuang YM, Li X, Yu YR, Tzeng SF, Teoh ST, et al. Immunoediting instructs tumor metabolic reprogramming to support immune evasion. Cell Metab. 2023;35(1):118\u2013e1337. https:\/\/doi.org\/10.1016\/j.cmet.2022.12.003. PubMed PMID: 36599297; PubMed Central PMCID: PMC10375941.","journal-title":"Cell Metab"},{"issue":"9","key":"2669_CR72","doi-asserted-by":"publisher","first-page":"4460","DOI":"10.3390\/ijms22094460","volume":"22","author":"N Di Ianni","year":"2021","unstructured":"Di Ianni N, Musio S, Pellegatta S. Altered Metabolism in Glioblastoma: Myeloid-Derived Suppressor Cell (MDSC) Fitness and Tumor-Infiltrating Lymphocyte (TIL) Dysfunction. Int J Mol Sci. 2021;22(9):4460. https:\/\/doi.org\/10.3390\/ijms22094460. PubMed PMID: 33923299; PubMed Central PMCID: PMC8123145.","journal-title":"Int J Mol Sci"},{"key":"2669_CR73","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1146\/annurev-immunol-032712-095956","volume":"31","author":"NJ MacIver","year":"2013","unstructured":"MacIver NJ, Michalek RD, Rathmell JC. Metabolic regulation of T lymphocytes. Annu Rev Immunol. 2013;31:259\u201383. https:\/\/doi.org\/10.1146\/annurev-immunol-032712-095956. PubMed PMID: 23298210; PubMed Central PMCID: PMC3606674.","journal-title":"Annu Rev Immunol"},{"issue":"6","key":"2669_CR74","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.cell.2013.05.016","volume":"153","author":"CH Chang","year":"2013","unstructured":"Chang CH, Curtis JD, Maggi LB, Faubert B, Villarino AV, O\u2019Sullivan D, et al. Posttranscriptional control of T cell effector function by aerobic glycolysis. Cell. 2013;153(6):1239\u201351. https:\/\/doi.org\/10.1016\/j.cell.2013.05.016. PubMed PMID: 23746840; PubMed Central PMCID: PMC3804311.","journal-title":"Cell"},{"issue":"1","key":"2669_CR75","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s40364-024-00646-1","volume":"12","author":"H Zhang","year":"2024","unstructured":"Zhang H, Li S, Wang D, Liu S, Xiao T, Gu W, et al. Metabolic reprogramming and immune evasion: the interplay in the tumor microenvironment. Biomark Res. 2024;12(1):96. https:\/\/doi.org\/10.1186\/s40364-024-00646-1. PubMed PMID: 39227970; PubMed Central PMCID: PMC11373140.","journal-title":"Biomark Res"},{"key":"2669_CR76","doi-asserted-by":"publisher","first-page":"1032360","DOI":"10.3389\/fcell.2022.1032360","volume":"10","author":"V Valvo","year":"2022","unstructured":"Valvo V, Parietti E, Deans K, Ahn SW, Park NR, Ferland B, et al. High-throughput in situ perturbation of metabolite levels in the tumor micro-environment reveals favorable metabolic condition for increased fitness of infiltrated T-cells. Front Cell Dev Biol. 2022;10:1032360. https:\/\/doi.org\/10.3389\/fcell.2022.1032360. PubMed PMID: 36619865; PubMed Central PMCID: PMC9815512.","journal-title":"Front Cell Dev Biol"},{"key":"2669_CR77","doi-asserted-by":"publisher","first-page":"969563","DOI":"10.3389\/fonc.2022.969563","volume":"12","author":"T Zhao","year":"2022","unstructured":"Zhao T, Lum JJ. Methionine cycle-dependent regulation of T cells in cancer immunity. Front Oncol. 2022;12:969563. https:\/\/doi.org\/10.3389\/fonc.2022.969563. PubMed PMID: 36033438; PubMed Central PMCID: PMC9399763.","journal-title":"Front Oncol"},{"issue":"6","key":"2669_CR78","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.ccell.2025.03.015","volume":"43","author":"Y Zhu","year":"2025","unstructured":"Zhu Y, Zhou Z, Du X, Lin X, Liang ZM, Chen S, et al. Cancer cell-derived arginine fuels polyamine biosynthesis in tumor-associated macrophages to promote immune evasion. Cancer Cell. 2025;43(6):1045\u2013e10607. https:\/\/doi.org\/10.1016\/j.ccell.2025.03.015. PubMed PMID: 40185095.","journal-title":"Cancer Cell"},{"issue":"2","key":"2669_CR79","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1002\/eji.200535616","volume":"36","author":"WP Weber","year":"2006","unstructured":"Weber WP, Feder-Mengus C, Chiarugi A, Rosenthal R, Reschner A, Schumacher R, et al. Differential effects of the tryptophan metabolite 3-hydroxyanthranilic acid on the proliferation of human CD8\u2009+\u2009T cells induced by TCR triggering or homeostatic cytokines. Eur J Immunol. 2006;36(2):296\u2013304. https:\/\/doi.org\/10.1002\/eji.200535616. PubMed PMID: 16385630.","journal-title":"Eur J Immunol"},{"issue":"1","key":"2669_CR80","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.molmed.2017.11.005","volume":"24","author":"L Zhang","year":"2018","unstructured":"Zhang L, Romero P. Metabolic Control of CD8\u2009+\u2009T Cell Fate Decisions and Antitumor Immunity. Trends Mol Med. 2018;24(1):30\u201348. https:\/\/doi.org\/10.1016\/j.molmed.2017.11.005. PubMed PMID: 29246759.","journal-title":"Trends Mol Med"},{"issue":"46","key":"2669_CR81","doi-asserted-by":"publisher","first-page":"75407","DOI":"10.18632\/oncotarget.12249","volume":"7","author":"CC Schafer","year":"2016","unstructured":"Schafer CC, Wang Y, Hough KP, Sawant A, Grant SC, Thannickal VJ, et al. Indoleamine 2,3-dioxygenase regulates anti-tumor immunity in lung cancer by metabolic reprogramming of immune cells in the tumor microenvironment. Oncotarget. 2016;7(46):75407\u201324. https:\/\/doi.org\/10.18632\/oncotarget.12249. PubMed PMID: 27705910; PubMed Central PMCID: PMC5340181.","journal-title":"Oncotarget"},{"issue":"1","key":"2669_CR82","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s40168-024-01907-9","volume":"12","author":"J Zhou","year":"2024","unstructured":"Zhou J, Hu Z, Wang L, Hu Q, Chen Z, Lin T, et al. Tumor-colonized Streptococcus mutans metabolically reprograms tumor microenvironment and promotes oral squamous cell carcinoma. Microbiome. 2024;12(1):193. https:\/\/doi.org\/10.1186\/s40168-024-01907-9. PubMed PMID: 39369210; PubMed Central PMCID: PMC11452938.","journal-title":"Microbiome"},{"issue":"8","key":"2669_CR83","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1016\/j.clnu.2023.06.011","volume":"42","author":"H Qiu","year":"2023","unstructured":"Qiu H, Shao N, Liu J, Zhao J, Chen C, Li Q, et al. Amino acid metabolism in tumor: New shine in the fog? Clin Nutr Edinb Scotl. 2023;42(8):1521\u201330. https:\/\/doi.org\/10.1016\/j.clnu.2023.06.011. PubMed PMID: 37321900.","journal-title":"Clin Nutr Edinb Scotl"},{"issue":"43","key":"2669_CR84","doi-asserted-by":"publisher","first-page":"e2403629","DOI":"10.1002\/advs.202403629","volume":"11","author":"X Zhou","year":"2024","unstructured":"Zhou X, Chen Z, Yu Y, Li M, Cao Y, Prochownik EV, et al. Increases in 4-Acetaminobutyric Acid Generated by Phosphomevalonate Kinase Suppress CD8\u2009+\u2009T Cell Activation and Allow Tumor Immune Escape. Adv Sci Weinh Baden-Wurtt Ger. 2024;11(43):e2403629. https:\/\/doi.org\/10.1002\/advs.202403629. PubMed PMID: 39325640; PubMed Central PMCID: PMC11578309.","journal-title":"Adv Sci Weinh Baden-Wurtt Ger"},{"issue":"1","key":"2669_CR85","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1080\/15548627.2023.2249762","volume":"20","author":"W Li","year":"2024","unstructured":"Li W, Zhou C, Yu L, Hou Z, Liu H, Kong L, et al. Tumor-derived lactate promotes resistance to bevacizumab treatment by facilitating autophagy enhancer protein RUBCNL expression through histone H3 lysine 18 lactylation (H3K18la) in colorectal cancer. Autophagy. 2024;20(1):114\u201330. .2249762 PubMed PMID: 37615625; PubMed Central PMCID: PMC10761097.","journal-title":"Autophagy"},{"issue":"6","key":"2669_CR86","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.3390\/cancers13061229","volume":"13","author":"SM Rad","year":"2021","unstructured":"Rad SM, AH, Halpin JC, Mollaei M, Smith Bell SWJ, Hirankarn N, McLellan AD. Metabolic and Mitochondrial Functioning in Chimeric Antigen Receptor (CAR)-T Cells. Cancers. 2021;13(6):1229. https:\/\/doi.org\/10.3390\/cancers13061229. PubMed PMID: 33799768; PubMed Central PMCID: PMC8002030.","journal-title":"Cancers"},{"issue":"1","key":"2669_CR87","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s12672-024-01034-9","volume":"15","author":"CE Holbert","year":"2024","unstructured":"Holbert CE, Casero RA, Stewart TM. Polyamines: the pivotal amines in influencing the tumor microenvironment. Discov Oncol. 2024;15(1):173. https:\/\/doi.org\/10.1007\/s12672-024-01034-9. PubMed PMID: 38761252; PubMed Central PMCID: PMC11102423.","journal-title":"Discov Oncol"},{"issue":"1","key":"2669_CR88","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1038\/s41467-021-21804-1","volume":"12","author":"MH Hung","year":"2021","unstructured":"Hung MH, Lee JS, Ma C, Diggs LP, Heinrich S, Chang CW, et al. Tumor methionine metabolism drives T-cell exhaustion in hepatocellular carcinoma. Nat Commun. 2021;12(1):1455. https:\/\/doi.org\/10.1038\/s41467-021-21804-1. PubMed PMID: 33674593; PubMed Central PMCID: PMC7935900.","journal-title":"Nat Commun"},{"key":"2669_CR89","doi-asserted-by":"publisher","first-page":"106661","DOI":"10.1016\/j.biocel.2024.106661","volume":"176","author":"J Shentu","year":"2024","unstructured":"Shentu J, Su X, Yu Y, Duan S. Unveiling the role of taurine and SLC6A6 in tumor immune evasion: Implications for gastric cancer therapy. Int J Biochem Cell Biol. 2024;176:106661. https:\/\/doi.org\/10.1016\/j.biocel.2024.106661. PubMed PMID: 39270578.","journal-title":"Int J Biochem Cell Biol"},{"key":"2669_CR90","doi-asserted-by":"publisher","unstructured":"Chang CH, Pearce EL. Emerging concepts of T cell metabolism as a target of immunotherapy. Nat Immunol. 2016;17(4):364\u20138. https:\/\/doi.org\/10.1038\/ni.3415. PubMed PMID: 27002844; PubMed Central PMCID: PMC4990080.","DOI":"10.1038\/ni.3415"},{"key":"2669_CR91","doi-asserted-by":"publisher","first-page":"1122789","DOI":"10.3389\/fonc.2023.1122789","volume":"13","author":"A Mehta","year":"2023","unstructured":"Mehta A, Ratre YK, Soni VK, Shukla D, Sonkar SC, Kumar A, et al. Orchestral role of lipid metabolic reprogramming in T-cell malignancy. Front Oncol. 2023;13:1122789. https:\/\/doi.org\/10.3389\/fonc.2023.1122789. PubMed PMID: 37256177; PubMed Central PMCID: PMC10226149.","journal-title":"Front Oncol"},{"issue":"9","key":"2669_CR92","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1016\/j.immuni.2024.08.003","volume":"57","author":"Y Ping","year":"2024","unstructured":"Ping Y, Shan J, Qin H, Li F, Qu J, Guo R, et al. PD-1 signaling limits expression of phospholipid phosphatase 1 and promotes intratumoral CD8\u2009+\u2009T cell ferroptosis. Immunity. 2024;57(9):2122\u2013e21399. https:\/\/doi.org\/10.1016\/j.immuni.2024.08.003. PubMed PMID: 39208806.","journal-title":"Immunity"},{"issue":"8","key":"2669_CR93","doi-asserted-by":"publisher","first-page":"e20191920","DOI":"10.1084\/jem.20191920","volume":"217","author":"T Manzo","year":"2020","unstructured":"Manzo T, Prentice BM, Anderson KG, Raman A, Schalck A, Codreanu GS, et al. Accumulation of long-chain fatty acids in the tumor microenvironment drives dysfunction in intrapancreatic CD8\u2009+\u2009T cells. J Exp Med. 2020;217(8):e20191920. https:\/\/doi.org\/10.1084\/jem.20191920. PubMed PMID: 32491160; PubMed Central PMCID: PMC7398173.","journal-title":"J Exp Med"},{"issue":"1","key":"2669_CR94","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13046-023-02634-z","volume":"42","author":"S Tan","year":"2023","unstructured":"Tan S, Yang Y, Yang W, Han Y, Huang L, Yang R, et al. Exosomal cargos-mediated metabolic reprogramming in tumor microenvironment. J Exp Clin Cancer Res CR. 2023;42(1):59. https:\/\/doi.org\/10.1186\/s13046-023-02634-z. PubMed PMID: 36899389; PubMed Central PMCID: PMC9999652.","journal-title":"J Exp Clin Cancer Res CR"},{"issue":"7","key":"2669_CR95","first-page":"1676","volume":"63","author":"D Kudo","year":"2003","unstructured":"Kudo D, Rayman P, Horton C, Cathcart MK, Bukowski RM, Thornton M, et al. Gangliosides expressed by the renal cell carcinoma cell line SK-RC-45 are involved in tumor-induced apoptosis of T cells. Cancer Res. 2003;63(7):1676\u201383. PubMed PMID: 12670922.","journal-title":"Cancer Res"},{"issue":"12","key":"2669_CR96","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1038\/s41590-020-0793-3","volume":"21","author":"YR Yu","year":"2020","unstructured":"Yu YR, Imrichova H, Wang H, Chao T, Xiao Z, Gao M, et al. Disturbed mitochondrial dynamics in CD8\u2009+\u2009TILs reinforce T cell exhaustion. Nat Immunol. 2020;21(12):1540\u201351. https:\/\/doi.org\/10.1038\/s41590-020-0793-3. PubMed PMID: 33020660.","journal-title":"Nat Immunol"},{"key":"2669_CR97","doi-asserted-by":"publisher","first-page":"1364577","DOI":"10.3389\/fonc.2024.1364577","volume":"14","author":"Mdo Greier","year":"2024","unstructured":"Greier Mdo, Runge C, Dudas A, Hartl J, Santer R, Dejaco M. Cytotoxic response of tumor-infiltrating lymphocytes of head and neck cancer slice cultures under mitochondrial dysfunction. Front Oncol. 2024;14:1364577. https:\/\/doi.org\/10.3389\/fonc.2024.1364577. PubMed PMID: 38515569; PubMed Central PMCID: PMC10954813.","journal-title":"Front Oncol"},{"issue":"9","key":"2669_CR98","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/nri.2016.98","volume":"16","author":"O Leavy","year":"2016","unstructured":"Leavy O. T Cell responses: Defective mitochondria disrupt CD8(+) T cells. Nat Rev Immunol. 2016;16(9):534\u20135. https:\/\/doi.org\/10.1038\/nri.2016.98. PubMed PMID: 27558410.","journal-title":"Nat Rev Immunol"},{"issue":"21","key":"2669_CR99","doi-asserted-by":"publisher","first-page":"4707","DOI":"10.1158\/0008-5472.CAN-20-0524","volume":"80","author":"B Koss","year":"2020","unstructured":"Koss B, Shields BD, Taylor EM, Storey AJ, Byrum SD, Gies AJ, et al. Epigenetic Control of Cdkn2a.Arf Protects Tumor-Infiltrating Lymphocytes from Metabolic Exhaustion. Cancer Res. 2020;80(21):4707\u201319. https:\/\/doi.org\/10.1158\/0008-5472.CAN-20-0524. PubMed PMID: 33004350; PubMed Central PMCID: PMC7642172.","journal-title":"Cancer Res"},{"issue":"10","key":"2669_CR100","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1158\/2326-6066.CIR-21-0813","volume":"10","author":"RS Hesterberg","year":"2022","unstructured":"Hesterberg RS, Liu M, Elmarsafawi AG, Koomen JM, Welsh EA, Hesterberg SG, et al. TCR-Independent Metabolic Reprogramming Precedes Lymphoma-Driven Changes in T-cell Fate. Cancer Immunol Res. 2022;10(10):1263\u201379. https:\/\/doi.org\/10.1158\/2326-6066.CIR-21-0813. PubMed PMID: 35969234; PubMed Central PMCID: PMC9662872.","journal-title":"Cancer Immunol Res"},{"key":"2669_CR101","doi-asserted-by":"publisher","first-page":"1428596","DOI":"10.3389\/fimmu.2024.1428596","volume":"15","author":"Q Wang","year":"2024","unstructured":"Wang Q, Yin X, Huang X, Zhang L, Lu H. Impact of mitochondrial dysfunction on the antitumor effects of immune cells. Front Immunol. 2024;15:1428596. https:\/\/doi.org\/10.3389\/fimmu.2024.1428596. PubMed PMID: 39464876; PubMed Central PMCID: PMC11502362.","journal-title":"Front Immunol"},{"issue":"11","key":"2669_CR102","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1016\/j.celrep.2018.11.018","volume":"25","author":"L Simula","year":"2018","unstructured":"Simula L, Pacella I, Colamatteo A, Procaccini C, Cancila V, Bordi M, et al. Drp1 Controls Effective T Cell Immune-Surveillance by Regulating T Cell Migration, Proliferation, and cMyc-Dependent Metabolic Reprogramming. Cell Rep. 2018;25(11):3059\u2013e307310. https:\/\/doi.org\/10.1016\/j.celrep.2018.11.018. PubMed PMID: 30540939; PubMed Central PMCID: PMC6302735.","journal-title":"Cell Rep"},{"key":"2669_CR103","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.canlet.2020.12.021","volume":"500","author":"C Hayes","year":"2021","unstructured":"Hayes C, Donohoe CL, Davern M, Donlon NE. The oncogenic and clinical implications of lactate induced immunosuppression in the tumour microenvironment. Cancer Lett. 2021;500:75\u201386. https:\/\/doi.org\/10.1016\/j.canlet.2020.12.021. PubMed PMID: 33347908.","journal-title":"Cancer Lett"},{"key":"2669_CR104","doi-asserted-by":"publisher","first-page":"979154","DOI":"10.3389\/fonc.2022.979154","volume":"12","author":"A Bogdanov","year":"2022","unstructured":"Bogdanov A, Bogdanov A, Chubenko V, Volkov N, Moiseenko F, Moiseyenko V. Tumor acidity: From hallmark of cancer to target of treatment. Front Oncol. 2022;12:979154. https:\/\/doi.org\/10.3389\/fonc.2022.979154. PubMed PMID: 36106097; PubMed Central PMCID: PMC9467452.","journal-title":"Front Oncol"},{"key":"2669_CR105","doi-asserted-by":"publisher","unstructured":"Rothschild E, Banerjee D. Subverting Subversion: A Review on the Breast Cancer Microenvironment and Therapeutic Opportunities. Breast Cancer Basic Clin Res. 2015;9(Suppl 2):7\u201315. https:\/\/doi.org\/10.4137\/BCBCR.S29423. PubMed PMID: 26417204; PubMed Central PMCID: PMC4571991.","DOI":"10.4137\/BCBCR.S29423"},{"key":"2669_CR106","doi-asserted-by":"publisher","first-page":"115153","DOI":"10.1016\/j.bcp.2022.115153","volume":"202","author":"J Lei","year":"2022","unstructured":"Lei J, Yang Y, Lu Z, Pan H, Fang J, Jing B, et al. Taming metabolic competition via glycolysis inhibition for safe and potent tumor immunotherapy. Biochem Pharmacol. 2022;202:115153. https:\/\/doi.org\/10.1016\/j.bcp.2022.115153. PubMed PMID: 35750199.","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"2669_CR107","doi-asserted-by":"publisher","first-page":"e1614","DOI":"10.1002\/ctm2.1614","volume":"14","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Song H, Li M, Lu P. Histone lactylation bridges metabolic reprogramming and epigenetic rewiring in driving carcinogenesis: Oncometabolite fuels oncogenic transcription. Clin Transl Med. 2024;14(3):e1614. https:\/\/doi.org\/10.1002\/ctm2.1614. PubMed PMID: 38456209; PubMed Central PMCID: PMC10921234.","journal-title":"Clin Transl Med"},{"issue":"3","key":"2669_CR108","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.7150\/ijbs.104079","volume":"21","author":"Q Liu","year":"2025","unstructured":"Liu Q, Liu Z, Zhang X, Zeng A, Song L. Revisiting of Cancer Immunotherapy: Insight from the Dialogue between Glycolysis and PD-1\/PD-L1 Axis in the Tumor Microenvironment. Int J Biol Sci. 2025;21(3):1202\u201321. https:\/\/doi.org\/10.7150\/ijbs.104079. PubMed PMID: 39897050; PubMed Central PMCID: PMC11781164.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"2669_CR109","doi-asserted-by":"publisher","first-page":"4981","DOI":"10.1038\/s41467-022-32521-8","volume":"13","author":"Q Feng","year":"2022","unstructured":"Feng Q, Liu Z, Yu X, Huang T, Chen J, Wang J, et al. Lactate increases stemness of CD8\u2009+\u2009T cells to augment anti-tumor immunity. Nat Commun. 2022;13(1):4981. https:\/\/doi.org\/10.1038\/s41467-022-32521-8. PubMed PMID: 36068198; PubMed Central PMCID: PMC9448806.","journal-title":"Nat Commun"},{"issue":"2","key":"2669_CR110","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41590-022-01379-9","volume":"24","author":"PDA Vignali","year":"2023","unstructured":"Vignali PDA, DePeaux K, Watson MJ, Ye C, Ford BR, Lontos K, et al. Hypoxia drives CD39-dependent suppressor function in exhausted T cells to limit antitumor immunity. Nat Immunol. 2023;24(2):267\u201379. https:\/\/doi.org\/10.1038\/s41590-022-01379-9. PubMed PMID: 36543958; PubMed Central PMCID: PMC10402660.","journal-title":"Nat Immunol"},{"issue":"7693","key":"2669_CR111","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature25501","volume":"554","author":"S Mariathasan","year":"2018","unstructured":"Mariathasan S, Turley SJ, Nickles D, Castiglioni A, Yuen K, Wang Y, et al. TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. Nature. 2018;554(7693):544\u20138. https:\/\/doi.org\/10.1038\/nature25501. PubMed PMID: 29443960; PubMed Central PMCID: PMC6028240.","journal-title":"Nature"},{"key":"2669_CR112","doi-asserted-by":"publisher","unstructured":"Salmon H, Franciszkiewicz K, Damotte D, Dieu-Nosjean MC, Validire P, Trautmann A, et al. Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors. J Clin Invest. 2012;122(3):899\u2013910. https:\/\/doi.org\/10.1172\/JCI45817. PubMed PMID: 22293174; PubMed Central PMCID: PMC3287213.","DOI":"10.1172\/JCI45817"},{"issue":"2","key":"2669_CR113","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1136\/gutjnl-2025-335642","volume":"75","author":"S Xiang","year":"2026","unstructured":"Xiang S, Chen Y, Wang C, Wang M, He Y, Liu Z, et al. Alleviated T cell exhaustion and SLC1A3-mediated stroma-remodelling dictate chemoimmunotherapy efficacy in oesophageal squamous cell carcinoma. Gut. 2026;75(2):252\u201364. https:\/\/doi.org\/10.1136\/gutjnl-2025-335642. PubMed PMID: 40983502.","journal-title":"Gut"},{"issue":"1","key":"2669_CR114","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/hep.32348","volume":"77","author":"Y Fang","year":"2023","unstructured":"Fang Y, Liu W, Tang Z, Ji X, Zhou Y, Song S, et al. Monocarboxylate transporter 4 inhibition potentiates hepatocellular carcinoma immunotherapy through enhancing T cell infiltration and immune attack. Hepatology. 2023;77(1):109\u201323. https:\/\/doi.org\/10.1002\/hep.32348. PubMed PMID: 35043976.","journal-title":"Hepatology"},{"issue":"7577","key":"2669_CR115","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/nature15520","volume":"527","author":"D Peng","year":"2015","unstructured":"Peng D, Kryczek I, Nagarsheth N, Zhao L, Wei S, Wang W, et al. Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy. Nature. 2015;527(7577):249\u201353. https:\/\/doi.org\/10.1038\/nature15520. PubMed PMID: 26503055; PubMed Central PMCID: PMC4779053.","journal-title":"Nature"},{"issue":"25","key":"2669_CR116","doi-asserted-by":"publisher","first-page":"00003","DOI":"10.1016\/j.cytogfr.2025.01.003","volume":"S1359\u20136101","author":"WL Thuya","year":"2025","unstructured":"Thuya WL, Cao Y, Ho PCL, Wong ALA, Wang L, Zhou J, et al. Insights into IL-6\/JAK\/STAT3 signaling in the tumor microenvironment: Implications for cancer therapy. Cytokine Growth Factor Rev. 2025;S1359\u20136101(25):00003\u20136. https:\/\/doi.org\/10.1016\/j.cytogfr.2025.01.003. PubMed PMID: 39893129.","journal-title":"Cytokine Growth Factor Rev"},{"key":"2669_CR117","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/978-3-030-59038-3_15","volume":"1296","author":"K Wang","year":"2020","unstructured":"Wang K, He H. Pancreatic Tumor Microenvironment. Adv Exp Med Biol. 2020;1296:243\u201357. https:\/\/doi.org\/10.1007\/978-3-030-59038-3_15. PubMed PMID: 34185297.","journal-title":"Adv Exp Med Biol"},{"issue":"19","key":"2669_CR118","doi-asserted-by":"publisher","first-page":"4719","DOI":"10.3390\/ijms20194719","volume":"20","author":"C Laplagne","year":"2019","unstructured":"Laplagne C, Domagala M, Le Naour A, Quemerais C, Hamel D, Fourni\u00e9 JJ, et al. Latest Advances in Targeting the Tumor Microenvironment for Tumor Suppression. Int J Mol Sci. 2019;20(19):4719. https:\/\/doi.org\/10.3390\/ijms20194719. PubMed PMID: 31547627; PubMed Central PMCID: PMC6801830.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2669_CR119","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1186\/s13046-023-02913-9","volume":"42","author":"MC Stip","year":"2023","unstructured":"Stip MC, Teeuwen L, Dierselhuis MP, Leusen JHW, Krijgsman D. Targeting the myeloid microenvironment in neuroblastoma. J Exp Clin Cancer Res CR. 2023;42(1):337. https:\/\/doi.org\/10.1186\/s13046-023-02913-9. PubMed PMID: 38087370; PubMed Central PMCID: PMC10716967.","journal-title":"J Exp Clin Cancer Res CR"},{"issue":"1","key":"2669_CR120","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3390\/ph18010075","volume":"18","author":"H Sabit","year":"2025","unstructured":"Sabit H, Arneth B, Pawlik TM, Abdel-Ghany S, Ghazy A, Abdelazeem RM, et al. Leveraging Single-Cell Multi-Omics to Decode Tumor Microenvironment Diversity and Therapeutic Resistance. Pharm Basel Switz. 2025;18(1):75. https:\/\/doi.org\/10.3390\/ph18010075. PubMed PMID: 39861138; PubMed Central PMCID: PMC11768313.","journal-title":"Pharm Basel Switz"},{"issue":"5","key":"2669_CR121","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/labinvest.2017.19","volume":"97","author":"A Gieryng","year":"2017","unstructured":"Gieryng A, Pszczolkowska D, Walentynowicz KA, Rajan WD, Kaminska B. Immune microenvironment of gliomas. Lab Investig J Tech Methods Pathol. 2017;97(5):498\u2013518. https:\/\/doi.org\/10.1038\/labinvest.2017.19. PubMed PMID: 28287634.","journal-title":"Lab Investig J Tech Methods Pathol"},{"key":"2669_CR122","doi-asserted-by":"publisher","first-page":"215795","DOI":"10.1016\/j.canlet.2022.215795","volume":"543","author":"TW Chen","year":"2022","unstructured":"Chen TW, Hung WZ, Chiang SF, Chen WTL, Ke TW, Liang JA, et al. Dual inhibition of TGF\u03b2 signaling and CSF1\/CSF1R reprograms tumor-infiltrating macrophages and improves response to chemotherapy via suppressing PD-L1. Cancer Lett. 2022;543:215795. https:\/\/doi.org\/10.1016\/j.canlet.2022.215795. PubMed PMID: 35718267.","journal-title":"Cancer Lett"},{"issue":"10","key":"2669_CR123","doi-asserted-by":"publisher","first-page":"e003217","DOI":"10.1136\/jitc-2021-003217","volume":"9","author":"F Ma","year":"2021","unstructured":"Ma F, Vayalil J, Lee G, Wang Y, Peng G. Emerging role of tumor-derived extracellular vesicles in T cell suppression and dysfunction in the tumor microenvironment. J Immunother Cancer. 2021;9(10):e003217. https:\/\/doi.org\/10.1136\/jitc-2021-003217. PubMed PMID: 34642246; PubMed Central PMCID: PMC8513270.","journal-title":"J Immunother Cancer"},{"issue":"7","key":"2669_CR124","doi-asserted-by":"publisher","first-page":"923","DOI":"10.4049\/jimmunol.2400335","volume":"213","author":"TL Whiteside","year":"2024","unstructured":"Whiteside TL. Tumor-derived Exosomes and Antitumor Immunity. J Immunol Baltim Md 1950. 2024;213(7):923\u201331. https:\/\/doi.org\/10.4049\/jimmunol.2400335. PubMed PMID: 39284119; PubMed Central PMCID: PMC11951267.","journal-title":"J Immunol Baltim Md 1950"},{"issue":"10","key":"2669_CR125","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.3390\/ijms20102416","volume":"20","author":"D Aldinucci","year":"2019","unstructured":"Aldinucci D, Borghese C, Casagrande N. Formation of the Immunosuppressive Microenvironment of Classic Hodgkin Lymphoma and Therapeutic Approaches to Counter It. Int J Mol Sci. 2019;20(10):2416. https:\/\/doi.org\/10.3390\/ijms20102416. PubMed PMID: 31096713; PubMed Central PMCID: PMC6566335.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2669_CR126","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/imm.13587","volume":"168","author":"WH Chang","year":"2023","unstructured":"Chang WH, Hsu SW, Zhang J, Li JM, Yang DD, Chu CW, et al. MTAP deficiency contributes to immune landscape remodelling and tumour evasion. Immunology. 2023;168(2):331\u201345. https:\/\/doi.org\/10.1111\/imm.13587. PubMed PMID: 36183155; PubMed Central PMCID: PMC9840685.","journal-title":"Immunology"},{"issue":"10","key":"2669_CR127","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1016\/j.immuni.2024.08.015","volume":"57","author":"Z Nian","year":"2024","unstructured":"Nian Z, Dou Y, Shen Y, Liu J, Du X, Jiang Y, et al. Interleukin-34-orchestrated tumor-associated macrophage reprogramming is required for tumor immune escape driven by p53 inactivation. Immunity. 2024;57(10):2344\u2013e23617. https:\/\/doi.org\/10.1016\/j.immuni.2024.08.015. PubMed PMID: 39321806.","journal-title":"Immunity"},{"issue":"1","key":"2669_CR128","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1038\/s41467-024-45084-7","volume":"15","author":"R Sun","year":"2024","unstructured":"Sun R, Lei C, Xu Z, Gu X, Huang L, Chen L, et al. Neutral ceramidase regulates breast cancer progression by metabolic programming of TREM2-associated macrophages. Nat Commun. 2024;15(1):966. https:\/\/doi.org\/10.1038\/s41467-024-45084-7. PubMed PMID: 38302493; PubMed Central PMCID: PMC10834982.","journal-title":"Nat Commun"},{"issue":"3","key":"2669_CR129","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/s41418-024-01409-z","volume":"32","author":"Y Sun","year":"2025","unstructured":"Sun Y, Zhou P, Qian J, Zeng Q, Wei G, Li Y, et al. Spermine synthase engages in macrophages M2 polarization to sabotage antitumor immunity in hepatocellular carcinoma. Cell Death Differ. 2025;32(3):573\u201386. https:\/\/doi.org\/10.1038\/s41418-024-01409-z. PubMed PMID: 39658701; PubMed Central PMCID: PMC11894157.","journal-title":"Cell Death Differ"},{"key":"2669_CR130","doi-asserted-by":"publisher","unstructured":"Al-Khami AA, Zheng L, Del Valle L, Hossain F, Wyczechowska D, Zabaleta J, et al. Exogenous lipid uptake induces metabolic and functional reprogramming of tumor-associated myeloid-derived suppressor cells. Oncoimmunology. 2017;6(10):e1344804. https:\/\/doi.org\/10.1080\/2162402X.2017.1344804. PubMed PMID: 29123954; PubMed Central PMCID: PMC5665069.","DOI":"10.1080\/2162402X.2017.1344804"},{"key":"2669_CR131","doi-asserted-by":"publisher","first-page":"112788","DOI":"10.1016\/j.intimp.2024.112788","volume":"140","author":"G Wu","year":"2024","unstructured":"Wu G, Pan B, Shi H, Yi Y, Zheng X, Ma H, et al. Neutrophils\u2019 dual role in cancer: from tumor progression to immunotherapeutic potential. Int Immunopharmacol. 2024;140:112788. https:\/\/doi.org\/10.1016\/j.intimp.2024.112788. PubMed PMID: 39083923.","journal-title":"Int Immunopharmacol"},{"key":"2669_CR132","doi-asserted-by":"publisher","unstructured":"Mullard A. Cancer cells poison the immune system with tainted mitochondria. Nature. 2025;22. https:\/\/doi.org\/10.1038\/d41586-025-00176-2. PubMed PMID: 39843701.","DOI":"10.1038\/d41586-025-00176-2"},{"issue":"4","key":"2669_CR133","doi-asserted-by":"publisher","first-page":"113995","DOI":"10.1016\/j.celrep.2024.113995","volume":"43","author":"Z Zou","year":"2024","unstructured":"Zou Z, Cheng Q, Zhou J, Guo C, Hadjinicolaou AV, Salio M, et al. ATF4-SLC7A11-GSH axis mediates the acquisition of immunosuppressive properties by activated CD4\u2009+\u2009T cells in low arginine condition. Cell Rep. 2024;43(4):113995. https:\/\/doi.org\/10.1016\/j.celrep.2024.113995. PubMed PMID: 38527061.","journal-title":"Cell Rep"},{"issue":"1","key":"2669_CR134","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1093\/intimm\/dxaa046","volume":"33","author":"A Kumar","year":"2021","unstructured":"Kumar A, Chamoto K. Immune metabolism in PD-1 blockade-based cancer immunotherapy. Int Immunol. 2021;33(1):17\u201326. https:\/\/doi.org\/10.1093\/intimm\/dxaa046. PubMed PMID: 32622347; PubMed Central PMCID: PMC7771015.","journal-title":"Int Immunol"},{"key":"2669_CR135","doi-asserted-by":"publisher","first-page":"1082195","DOI":"10.3389\/fcell.2022.1082195","volume":"10","author":"MK Blake","year":"2022","unstructured":"Blake MK, O\u2019Connell P, Aldhamen YA. Fundamentals to therapeutics: Epigenetic modulation of CD8\u2009+\u2009T Cell exhaustion in the tumor microenvironment. Front Cell Dev Biol. 2022;10:1082195. https:\/\/doi.org\/10.3389\/fcell.2022.1082195. PubMed PMID: 36684449; PubMed Central PMCID: PMC9846628.","journal-title":"Front Cell Dev Biol"},{"key":"2669_CR136","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.ncrna.2024.10.005","volume":"10","author":"Z Ding","year":"2025","unstructured":"Ding Z, Wu B, Yang J, Wang D, Qiao J, Guo F. Glycolysis regulated exosomal LINC01214 inhibited CD8\u2009+\u2009T cell function and induced anti-PD1 resistance in melanoma via modulating miR-4492\/PPP1R11 axis. Non-Coding RNA Res. 2025;10:242\u201351. https:\/\/doi.org\/10.1016\/j.ncrna.2024.10.005. PubMed PMID: 39559293; PubMed Central PMCID: PMC11570817.","journal-title":"Non-Coding RNA Res"},{"issue":"4","key":"2669_CR137","doi-asserted-by":"publisher","first-page":"e2101320","DOI":"10.1002\/adbi.202101320","volume":"7","author":"HI Aksoylar","year":"2023","unstructured":"Aksoylar HI, Patsoukis N. Treatment with Exogenously Added Catalase Alters CD8 T Cell Memory Differentiation and Function. Adv Biol. 2023;7(4):e2101320. https:\/\/doi.org\/10.1002\/adbi.202101320. PubMed PMID: 35481698; PubMed Central PMCID: PMC9613814.","journal-title":"Adv Biol"},{"issue":"4","key":"2669_CR138","doi-asserted-by":"publisher","first-page":"e2204808","DOI":"10.1002\/advs.202204808","volume":"10","author":"J Zhao","year":"2023","unstructured":"Zhao J, Tian Z, Zhao S, Feng D, Guo Z, Wen L, et al. Insights into the Effect of Catalytic Intratumoral Lactate Depletion on Metabolic Reprogramming and Immune Activation for Antitumoral Activity. Adv Sci Weinh Baden-Wurtt Ger. 2023;10(4):e2204808. https:\/\/doi.org\/10.1002\/advs.202204808. PubMed PMID: 36479819; PubMed Central PMCID: PMC9896070.","journal-title":"Adv Sci Weinh Baden-Wurtt Ger"},{"issue":"21","key":"2669_CR139","doi-asserted-by":"publisher","first-page":"3589","DOI":"10.1158\/0008-5472.CAN-23-3513","volume":"84","author":"C Zhang","year":"2024","unstructured":"Zhang C, Zhou L, Zhang M, Du Y, Li C, Ren H, et al. H3K18 Lactylation Potentiates Immune Escape of Non-Small Cell Lung Cancer. Cancer Res. 2024;84(21):3589\u2013601. https:\/\/doi.org\/10.1158\/0008-5472.CAN-23-3513. PubMed PMID: 39137401.","journal-title":"Cancer Res"},{"issue":"14","key":"2669_CR140","doi-asserted-by":"publisher","first-page":"3892","DOI":"10.1039\/d2bm00650b","volume":"10","author":"LR Tian","year":"2022","unstructured":"Tian LR, Lin MZ, Zhong HH, Cai YJ, Li B, Xiao ZC, et al. Nanodrug regulates lactic acid metabolism to reprogram the immunosuppressive tumor microenvironment for enhanced cancer immunotherapy. Biomater Sci. 2022;10(14):3892\u2013900. https:\/\/doi.org\/10.1039\/d2bm00650b. PubMed PMID: 35686599.","journal-title":"Biomater Sci"},{"key":"2669_CR141","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.trsl.2019.12.005","volume":"217","author":"G Agnello","year":"2020","unstructured":"Agnello G, Alters SE, Rowlinson SW. Preclinical safety and antitumor activity of the arginine-degrading therapeutic enzyme pegzilarginase, a PEGylated, cobalt-substituted recombinant human arginase 1. Transl Res J Lab Clin Med. 2020;217:11\u201322. https:\/\/doi.org\/10.1016\/j.trsl.2019.12.005. PubMed PMID: 31954097.","journal-title":"Transl Res J Lab Clin Med"},{"issue":"5","key":"2669_CR142","first-page":"1952","volume":"13","author":"PH Ye","year":"2023","unstructured":"Ye PH, Li CY, Cheng HY, Anuraga G, Wang CY, Chen FW, et al. A novel combination therapy of arginine deiminase and an arginase inhibitor targeting arginine metabolism in the tumor and immune microenvironment. Am J Cancer Res. 2023;13(5):1952\u201369. PubMed PMID: 37293150; PubMed Central PMCID: PMC10244097.","journal-title":"Am J Cancer Res"},{"issue":"12","key":"2669_CR143","doi-asserted-by":"publisher","first-page":"11349","DOI":"10.18632\/aging.103113","volume":"12","author":"S Jiang","year":"2020","unstructured":"Jiang S, Li H, Piao L, Jin Z, Liu J, Chen S, et al. Computational study on new natural compound inhibitors of indoleamine 2,3-dioxygenase 1. Aging. 2020;12(12):11349\u201363. https:\/\/doi.org\/10.18632\/aging.103113. PubMed PMID: 32568737; PubMed Central PMCID: PMC7343476.","journal-title":"Aging"},{"issue":"14","key":"2669_CR144","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1158\/0008-5472.CAN-22-3042","volume":"83","author":"X Huang","year":"2023","unstructured":"Huang X, Sun T, Wang J, Hong X, Chen H, Yan T, et al. Metformin Reprograms Tryptophan Metabolism to Stimulate CD8\u2009+\u2009T-cell Function in Colorectal Cancer. Cancer Res. 2023;83(14):2358\u201371. https:\/\/doi.org\/10.1158\/0008-5472.CAN-22-3042. PubMed PMID: 37195082.","journal-title":"Cancer Res"},{"key":"2669_CR145","doi-asserted-by":"publisher","first-page":"1204363","DOI":"10.3389\/fimmu.2023.1204363","volume":"14","author":"Q Guan","year":"2023","unstructured":"Guan Q, Han M, Guo Q, Yan F, Wang M, Ning Q, et al. Strategies to reinvigorate exhausted CD8\u2009+\u2009T cells in tumor microenvironment. Front Immunol. 2023;14:1204363. https:\/\/doi.org\/10.3389\/fimmu.2023.1204363. PubMed PMID: 37398660; PubMed Central PMCID: PMC10311918.","journal-title":"Front Immunol"},{"issue":"4","key":"2669_CR146","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1002\/eji.202149486","volume":"52","author":"A Bevilacqua","year":"2022","unstructured":"Bevilacqua A, Li Z, Ho PC. Metabolic dynamics instruct CD8\u2009+\u2009T-cell differentiation and functions. Eur J Immunol. 2022;52(4):541\u20139. https:\/\/doi.org\/10.1002\/eji.202149486. PubMed PMID: 35253907; PubMed Central PMCID: PMC9314626.","journal-title":"Eur J Immunol"},{"issue":"2","key":"2669_CR147","doi-asserted-by":"publisher","first-page":"669","DOI":"10.3390\/ijms26020669","volume":"26","author":"Y Vijayanathan","year":"2025","unstructured":"Vijayanathan Y, Ho IAW. The Impact of Metabolic Rewiring in Glioblastoma: The Immune Landscape and Therapeutic Strategies. Int J Mol Sci. 2025;26(2):669. https:\/\/doi.org\/10.3390\/ijms26020669. PubMed PMID: 39859381; PubMed Central PMCID: PMC11765942.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"2669_CR148","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1182\/bloodadvances.2024014822","volume":"9","author":"W Gamal","year":"2025","unstructured":"Gamal W, Goedhart NB, Simon-Molas H, Mediavilla-Varela M, Uriepero-Palma A, Peters FS, et al. Mitigating T-cell mitochondrial dysfunction in CLL to augment CAR T-cell therapy: evaluation in an immunocompetent model. Blood Adv. 2025;9(10):2511\u201329. https:\/\/doi.org\/10.1182\/bloodadvances.2024014822. PubMed PMID: 39938006; PubMed Central PMCID: PMC12148389.","journal-title":"Blood Adv"},{"issue":"Pt A","key":"2669_CR149","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jcis.2023.09.042","volume":"653","author":"Y Xia","year":"2024","unstructured":"Xia Y, Gu M, Wang J, Zhang X, Shen T, Shi X, et al. Tumor microenvironment-activated, immunomodulatory nanosheets loaded with copper(II) and 5-FU for synergistic chemodynamic therapy and chemotherapy. J Colloid Interface Sci. 2024;653(Pt A):137\u201347. https:\/\/doi.org\/10.1016\/j.jcis.2023.09.042. PubMed PMID: 37713912.","journal-title":"J Colloid Interface Sci"},{"issue":"32","key":"2669_CR150","doi-asserted-by":"publisher","first-page":"e2202663","DOI":"10.1002\/smll.202202663","volume":"18","author":"D Zhang","year":"2022","unstructured":"Zhang D, Li Q, Chen X, Nie X, Xue F, Xu W, et al. An Injectable Hydrogel to Modulate T Cells for Cancer Immunotherapy. Small Weinh Bergstr Ger. 2022;18(32):e2202663. https:\/\/doi.org\/10.1002\/smll.202202663. PubMed PMID: 35843879.","journal-title":"Small Weinh Bergstr Ger"},{"issue":"38","key":"2669_CR151","doi-asserted-by":"publisher","first-page":"17699","DOI":"10.1039\/d4nr01780c","volume":"16","author":"K Wells","year":"2024","unstructured":"Wells K, Liu T, Zhu L, Yang L. Immunomodulatory nanoparticles activate cytotoxic T cells for enhancement of the effect of cancer immunotherapy. Nanoscale. 2024;16(38):17699\u2013722. https:\/\/doi.org\/10.1039\/d4nr01780c. PubMed PMID: 39257225; PubMed Central PMCID: PMC12139611.","journal-title":"Nanoscale"},{"key":"2669_CR152","doi-asserted-by":"publisher","unstructured":"Holmgaard RB, Brachfeld A, Gasmi B, Jones DR, Mattar M, Doman T, et al. Timing of CSF-1\/CSF-1R signaling blockade is critical to improving responses to CTLA-4 based immunotherapy. Oncoimmunology. 2016;5(7):e1151595. https:\/\/doi.org\/10.1080\/2162402X.2016.1151595. PubMed PMID: 27622016; PubMed Central PMCID: PMC5006914.","DOI":"10.1080\/2162402X.2016.1151595"},{"key":"2669_CR153","doi-asserted-by":"publisher","unstructured":"Wherry EJ, Kurachi M. Molecular and cellular insights into T cell exhaustion. Nat Rev Immunol. 2015;15(8):486\u201399. https:\/\/doi.org\/10.1038\/nri3862. PubMed PMID: 26205583; PubMed Central PMCID: PMC4889009.","DOI":"10.1038\/nri3862"},{"issue":"12","key":"2669_CR154","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1084\/jem.20030152","volume":"198","author":"W Chen","year":"2003","unstructured":"Chen W, Jin W, Hardegen N, Lei KJ, Li L, Marinos N, et al. Conversion of peripheral CD4\u2009+\u2009CD25- naive T cells to CD4\u2009+\u2009CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med. 2003;198(12):1875\u201386. https:\/\/doi.org\/10.1084\/jem.20030152. PubMed PMID: 14676299; PubMed Central PMCID: PMC2194145.","journal-title":"J Exp Med"},{"issue":"7655","key":"2669_CR155","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/nature22367","volume":"545","author":"M Philip","year":"2017","unstructured":"Philip M, Fairchild L, Sun L, Horste EL, Camara S, Shakiba M, et al. Chromatin states define tumour-specific T cell dysfunction and reprogramming. Nature. 2017;545(7655):452\u20136. https:\/\/doi.org\/10.1038\/nature22367. PubMed PMID: 28514453; PubMed Central PMCID: PMC5693219.","journal-title":"Nature"},{"issue":"1","key":"2669_CR156","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12943-023-01924-6","volume":"23","author":"S Zhang","year":"2024","unstructured":"Zhang S, Liu Y, Sun Y, Liu Q, Gu Y, Huang Y, et al. Aberrant R-loop-mediated immune evasion, cellular communication, and metabolic reprogramming affect cancer progression: a single-cell analysis. Mol Cancer. 2024;23(1):11. https:\/\/doi.org\/10.1186\/s12943-023-01924-6. PubMed PMID: 38200551; PubMed Central PMCID: PMC10777569.","journal-title":"Mol Cancer"},{"issue":"1","key":"2669_CR157","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s13045-022-01351-y","volume":"15","author":"M Nikanjam","year":"2022","unstructured":"Nikanjam M, Kato S, Kurzrock R. Liquid biopsy: current technology and clinical applications. J Hematol OncolJ Hematol Oncol. 2022;15(1):131. https:\/\/doi.org\/10.1186\/s13045-022-01351-y. PubMed PMID: 36096847; PubMed Central PMCID: PMC9465933.","journal-title":"J Hematol OncolJ Hematol Oncol"},{"issue":"5","key":"2669_CR158","doi-asserted-by":"publisher","first-page":"e2203699","DOI":"10.1002\/advs.202203699","volume":"10","author":"Y Zou","year":"2023","unstructured":"Zou Y, Ye F, Kong Y, Hu X, Deng X, Xie J, et al. The Single-Cell Landscape of Intratumoral Heterogeneity and The Immunosuppressive Microenvironment in Liver and Brain Metastases of Breast Cancer. Adv Sci Weinh Baden-Wurtt Ger. 2023;10(5):e2203699. https:\/\/doi.org\/10.1002\/advs.202203699. PubMed PMID: 36529697; PubMed Central PMCID: PMC9929130.","journal-title":"Adv Sci Weinh Baden-Wurtt Ger"},{"key":"2669_CR159","doi-asserted-by":"publisher","unstructured":"Magkouta S, Markaki E, Evangelou K, Petty R, Verginis P, Gorgoulis V. Decoding T cell senescence in cancer: Is revisiting required? Semin Cancer Biol. 2025;108:33\u201347. https:\/\/doi.org\/10.1016\/j.semcancer.2024.11.003. PubMed PMID: 39615809.","DOI":"10.1016\/j.semcancer.2024.11.003"},{"key":"2669_CR160","doi-asserted-by":"publisher","unstructured":"Liu X, Hoft DF, Peng G. Senescent T cells within suppressive tumor microenvironments: emerging target for tumor immunotherapy. J Clin Invest. 2020;130(3):1073\u201383. https:\/\/doi.org\/10.1172\/JCI133679. PubMed PMID: 32118585; PubMed Central PMCID: PMC7269563.","DOI":"10.1172\/JCI133679"},{"issue":"6","key":"2669_CR161","doi-asserted-by":"publisher","first-page":"e20241102","DOI":"10.1084\/jem.20241102","volume":"222","author":"AB Plata-G\u00f3mez","year":"2025","unstructured":"Plata-G\u00f3mez AB, Ho PC. Age- and diet-instructed metabolic rewiring of the tumor-immune microenvironment. J Exp Med. 2025;222(6):e20241102. https:\/\/doi.org\/10.1084\/jem.20241102. PubMed PMID: 40214641; PubMed Central PMCID: PMC11987706.","journal-title":"J Exp Med"},{"issue":"2","key":"2669_CR162","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/s41419-023-05560-2","volume":"14","author":"AH Mohseni","year":"2023","unstructured":"Mohseni AH, Taghinezhad-S S, Casolaro V, Lv Z, Li D. Potential links between the microbiota and T cell immunity determine the tumor cell fate. Cell Death Dis. 2023;14(2):154. https:\/\/doi.org\/10.1038\/s41419-023-05560-2. PubMed PMID: 36828830; PubMed Central PMCID: PMC9958015.","journal-title":"Cell Death Dis"},{"issue":"10","key":"2669_CR163","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1158\/2326-6066.CIR-22-0107","volume":"10","author":"R Peng","year":"2022","unstructured":"Peng R, Liu S, You W, Huang Y, Hu C, Gao Y, et al. Gastric Microbiome Alterations Are Associated with Decreased CD8\u2009+\u2009Tissue-Resident Memory T Cells in the Tumor Microenvironment of Gastric Cancer. Cancer Immunol Res. 2022;10(10):1224\u201340. https:\/\/doi.org\/10.1158\/2326-6066.CIR-22-0107. PubMed PMID: 35881964.","journal-title":"Cancer Immunol Res"},{"issue":"4","key":"2669_CR164","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/nm.3831","volume":"21","author":"JH Chen","year":"2015","unstructured":"Chen JH, Perry CJ, Tsui YC, Staron MM, Parish IA, Dominguez CX, et al. Prostaglandin E2 and programmed cell death 1 signaling coordinately impair CTL function and survival during chronic viral infection. Nat Med. 2015;21(4):327\u201334. https:\/\/doi.org\/10.1038\/nm.3831. PubMed PMID: 25799228; PubMed Central PMCID: PMC4505619.","journal-title":"Nat Med"},{"issue":"52","key":"2669_CR165","doi-asserted-by":"publisher","first-page":"89802","DOI":"10.18632\/oncotarget.21155","volume":"8","author":"J Miao","year":"2017","unstructured":"Miao J, Lu X, Hu Y, Piao C, Wu X, Liu X, et al. Prostaglandin E2 and PD-1 mediated inhibition of antitumor CTL responses in the human tumor microenvironment. Oncotarget. 2017;8(52):89802\u201310. https:\/\/doi.org\/10.18632\/oncotarget.21155. PubMed PMID: 29163789; PubMed Central PMCID: PMC5685710.","journal-title":"Oncotarget"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-026-02669-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-026-02669-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-026-02669-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T01:55:59Z","timestamp":1783043759000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12943-026-02669-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,11]]},"references-count":165,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2669"],"URL":"https:\/\/doi.org\/10.1186\/s12943-026-02669-8","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,11]]},"assertion":[{"value":"11 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"160"}}